Immunogenicity and protective efficacy of an RSV G S177Q central conserved domain nanoparticle vaccine

Overview of attention for article published in Frontiers in immunology, June 2023

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (52nd percentile)
Above-average Attention Score compared to outputs of the same age and source (60th percentile)

Mentioned by

twitter: 3 X users

Citations

dimensions_citation: 2 Dimensions

Readers on

mendeley: 4 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 33,840 followers.

Immunogenicity and protective efficacy of an RSV G S177Q central conserved domain nanoparticle vaccine https://t.co/AoNtng7kFg

17 Jul 2023

Reply Repost Favourite

RT @FrontImmunol: New Research: Immunogenicity and protective efficacy of an RSV G S177Q central conserved domain nanoparticle vaccine: Int…

29 Jun 2023

Reply Repost Favourite

New Research: Immunogenicity and protective efficacy of an RSV G S177Q central conserved domain nanoparticle vaccine: Introduction Respiratory syncytial virus (RSV) can cause lower respiratory tract disease in infants and elderly… #immunology https://t.co

29 Jun 2023

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.